In 2006 was created Yingke Capital, which is appeared as VC.
The high activity for fund was in 2018. The fund is constantly included in 2-6 investment rounds annually. Deals in the range of 10 - 50 millions dollars are the general things for fund. Speaking about the real fund results, this VC is 66 percentage points more often commits exit comparing to other organizations. This Yingke Capital works on 15 percentage points less the average amount of lead investments comparing to the other organizations. When the investment is from Yingke Capital the average startup value is more than 1 billion dollars.
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Yingke Capital, startups are often financed by Zhongtai Chuanghui Equity Investment Fund, Xiaomi, Warmsun Holding Group. The meaningful sponsors for the fund in investment in the same round are Yueyin Venture Capital, Tigermed, TF Capital. In the next rounds fund is usually obtained by Tianjin Haida Venture Capital Management, Shenzhen Capital Group, Share Capital.
The fund has exact preference in some founders of portfolio startups. Among the most successful fund investment fields, there are Biotechnology, Biopharma. Among the various public portfolio startups of the fund, we may underline Royole Corporation, Zelgen, Haihe Biopharma Besides, a startup needs to be aged 6-10 years to get the investment from the fund.
Related Funds
Fund Name | Location |
350 Investment Partners | England, United Kingdom, Warrington |
AJI Capital | Huntington, New York, United States |
Ayer Capital Management | California, San Francisco, United States |
Baicizhan | Chengdu, China, Sichuan |
Cairn Investment Group | - |
DRW Venture Partners | Austin, Texas, United States |
Ehong Capital Co., Ltd. | - |
Enpact | Berlin, Berlin, Germany |
F&M INVESTMENT OFFICE | - |
Fenqile | China, Guangdong, Shenzhen |
Guangkong Kangfu Yongpin | China, Hong Kong, Hong Kong Island |
Huaan Securities | Anhui, China, Hefei |
Impact51 | Kusnacht, Switzerland, Zurich |
M-Industry | Connecticut, Stamford, United States |
Omicron Capital | Missouri, St Louis, United States |
Orbis Investment Management | Bermuda, Hamilton |
Teamworthy Ventures | New York, New York, United States |
webMethods | Fairfax, United States, Virginia |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
WestGene Biopharma | $46M | 20 Jun 2023 | Chengdu, Sichuan, China | ||
Junde Pharmaceutical | 31 May 2023 | Xiamen, China | |||
Huizhou Yipeng Energy Technology Co., Ltd. | $27M | 05 Dec 2022 | Huizhou, Guangdong Province, China | ||
Chengmandian Energy Technology | $15M | 01 Dec 2022 | Chuzhou, Anhui, China | ||
Dreamworld AR | 11 Nov 2022 | San Mateo, California, United States | |||
SolarSpace | $463M | 01 Nov 2022 | Xuzhou, Jiangsu, China | ||
Fourier | 31 Aug 2022 | Xuhui, Shanghai, China | |||
Sunwoda Electric Vehicle Battery | $1B | 16 Aug 2022 | Shanghai, Shanghai, China | ||
Chinagene Tech | $15M | 30 Mar 2022 | Changping District, Beijing, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
WestGene Biopharma | $46M | 20 Jun 2023 | Chengdu, Sichuan, China | ||
Junde Pharmaceutical | 31 May 2023 | Xiamen, China | |||
Huizhou Yipeng Energy Technology Co., Ltd. | $27M | 05 Dec 2022 | Huizhou, Guangdong Province, China | ||
Chengmandian Energy Technology | $15M | 01 Dec 2022 | Chuzhou, Anhui, China | ||
Dreamworld AR | 11 Nov 2022 | San Mateo, California, United States | |||
SolarSpace | $463M | 01 Nov 2022 | Xuzhou, Jiangsu, China | ||
Fourier | 31 Aug 2022 | Xuhui, Shanghai, China | |||
Sunwoda Electric Vehicle Battery | $1B | 16 Aug 2022 | Shanghai, Shanghai, China | ||
Chinagene Tech | $15M | 30 Mar 2022 | Changping District, Beijing, China |